EGFR and breast cancer: For example, a recent report showed that neurotensin (NTS) and its high affinity receptor (NTSR1) enhances EGFR, HER2, and HER3 activation, but lapatinib could reduce the tumour growth of breast cancer cells overexpressing NTS and NTSR1 [43].